Sanibel Captiva Trust Company’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$781K Sell
8,632
-78
-0.9% -$6.53K 0.02% 278
2026
Q1
$697K Sell
8,710
-100
-1% -$8.24K 0.02% 269
2025
Q4
$751K Buy
8,810
+132
+2% +$10.8K 0.02% 254
2025
Q3
$675K Buy
8,678
+1,411
+19% +$110K 0.02% 260
2025
Q2
$568K Sell
7,267
-9
-0.1% -$671 0.02% 269
2025
Q1
$527K Sell
7,276
-96
-1% -$6.87K 0.02% 266
2024
Q4
$546K Sell
7,372
-817
-10% -$57.2K 0.02% 258
2024
Q3
$540K Buy
8,189
+143
+2% +$10.4K 0.02% 267
2024
Q2
$743K Hold
8,046
0.03% 229
2024
Q1
$769K Buy
8,046
+286
+4% +$24K 0.03% 218
2023
Q4
$592K Buy
+7,760
New +$540K 0.02% 226

Other funds holding EW

Sanibel Captiva Trust Company's EW Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Edwards Lifesciences (EW) stake by 0.9% in Q2 2026, selling an estimated $6.53K and leaving 8,632 shares worth $781K. The position accounts for 0.02% of the portfolio, ranked #278.

Sanibel Captiva Trust Company first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sanibel Captiva Trust Company held 8,632 shares of Edwards Lifesciences worth $781K as of Q2 2026.
  • Sanibel Captiva Trust Company sold 78 Edwards Lifesciences shares in Q2 2026, an estimated $6.53K.
  • Edwards Lifesciences made up 0.02% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #278 holding.
  • Sanibel Captiva Trust Company first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.